The largest database of trusted experimental protocols

8 protocols using il 15

1

SARS-CoV-2 S Protein-Induced NK Cell Responses

Check if the same lab product or an alternative is used in the 5 most similar protocols
For analysis of NK-cell related responses, an ELISA-based assay was used. Therefore, 96-well ELISA plates (Thermo Fisher) were coated with SARS-CoV-2 S at 37°C for 2h. Plates were then washed and blocked with 5% BSA in PBS overnight at 4°C. NK cells were isolated from buffy coats from healthy donors (MGH blood donor center) using the RosetteSep isolation kit (Stem Cell Technologies) and NK cells were rested overnight supplemented with IL-15 (Stemcell). Serum samples were diluted 1:50 and incubated at 37°C for 2h on the ELISA plates. A staining cocktail of anti-CD107a-PE-Cy5 stain (BD), brefeldin A (Sigma), and GolgiStop (BD) was added to the NK cells and 5×104 NK cells per well were added and incubated for 5h at 37°C. NK cells were fixed and permeabilized using Perm A and B (Thermo Fisher) and surface markers were stained for with anti-CD16 APC-Cy7 (BD), anti-CD56 PE-Cy7 (BD) and anti-CD3 AlexaFluor 700 antibodies (BD). Intracellular staining included anti-IFNγ APC (BD) and anti-MIP-1β PE (BD). Acquisition occurred by flow cytometry iQue (Intellicyt), equipped with a robot arm (PAA). NK cells were defined as CD3-, CD16+ and CD56+. The ADNKA assay was performed in duplicate across two blood donors.
+ Open protocol
+ Expand
2

Expansion and Activation of Human NK Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human NK cells were isolated from the peripheral blood of healthy donors using RosetteSep (Stem Cell Technologies, Vancouver, BC, Canada)—which depletes cluster of differentiation 3+ T cells and red blood cells—followed by CD56 magnetic beads (Miltenyi Biotec, Bergisch Gladbach, Germany). The cells were cultured in α Minimal Essential Medium (Welgene, Gyeongsan, Korea) with IL-15 (30 ng/ml), IL-21 (30 ng/ml), and 10−6 M of hydrocortisone (HC; Stem Cell Technologies, Canada). To investigate the effect of PGE2 on NK cell toxicity, the cells were cultured for 48 h with either control medium or thyroid cancer cell culture supernatant at 1/4 dilution.
+ Open protocol
+ Expand
3

Activating and Expanding Primary Human T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
This research
was performed in accordance with the Declaration of Helsinki. Human
peripheral blood was obtained from healthy adults after obtaining
informed consent (Technical University of Denmark-Rigshospitalet National
Hospital approval BC-40). T cells were isolated from the PBMC population
by immune-magnetic negative selection using the EasySep Human T Cell
Isolation Kit (STEMCELL Technologies). After isolation, T cells were
activated in 25 μL ImmunoCult Human CD3/CD28/CD2 T-Cell Activator
(STEMCELL Technologies) per 1 mL ImmunoCult-XF T Cell Expansion Medium
(STEMCELL Technologies) containing 12.5 ng mL–1 of
Human Recombinant IL-2, 5 ng mL–1 of IL-7, and 5
ng mL–1 of IL-15 (STEMCELL Technologies) and seeded
at 1.0 × 106 cells mL–1 until transfection
48 h later. The cells were maintained at 37 °C in 5% CO2 incubators.
+ Open protocol
+ Expand
4

Expansion and Purification of Human NK Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human PB NK cells were cultured on 6-well cell culture plates in Immunocult-XF T cell expansion medium (StemCell Technologies, Vancouver, BC, Canada) supplemented with 1× penicillin/streptomycin (VWR, Radnor, PA), 500 IU mL−1 IL-2 (StemCell Technologies), 0.2 μL mL−1 CD2/CD3/CD28 T cell activator (StemCell Technologies), and 10 ng mL−1 IL-15 (StemCell Technologies). Culture medium was replaced every 3 days, and cells were kept at a concentration no less than 1 × 106 cells mL−1. Human PB NK cells were expanded for 14–21 days prior to cell experiments. PB NK cells were purchased from StemCell Technologies. Cells were purified via FACS sorting using the surface marker CD56. All cell donors were ≥90% pure. SHSY5Y-GFP cells were cultured in RPMI 1640 (VWR, Radnor, PA) supplemented with 10% FBS (VWR, Radnor, PA) and 1× penicillin/streptomycin in T75 vented cell culture flasks. Cells were split every 2–3 days using trypsin (0.25%) (VWR, Radnor, PA).
+ Open protocol
+ Expand
5

Antibody-Dependent NK Cell Activation

Check if the same lab product or an alternative is used in the 5 most similar protocols
ELISA plates (NUNC, Thermo Fisher) were coated with HA antigens (H1 A/California/07/2009 and H3 A/Texas/50/2012), washed to remove unbound antigen, and blocked with 5% bovine serum albumin (Sigma) in PBS. Primary human NK cells were isolated from fresh buffy coats using the RosetteSep NK cell enrichment kit (StemCell) and rested overnight at 37C with 1 ng/ml IL-15 (StemCell). 1:25 diluted serum samples were added to the washed, HA-coated plates and incubated for 2 hours at 37C. Immediately prior to use, brefeldin A (Sigma), GolgiStop (BD), and fluorescent anti-CD107a (BD) were added to primary NK cells. Immune complexed plates were washed, and NK cells were added for 5 hours at 37C. After incubation, NK cells were removed and stained with fluorescent antibodies for cell surface markers CD3, CD56, and CD16 (BD). NK cells were fixed and permeabilized using Fixation & Permeabilization Media A & B (BD). Permeabilized NK cells were stained for intracellular makers MIP-1β and IFN-ɣ (BD). NK cells were quantified on the iQue Screener Plus using Forecyt software (Intellicyt). NK cells were defined as CD3 negative, CD16 positive. Each sample was assayed on two buffy coat donors.
+ Open protocol
+ Expand
6

SARS-CoV-2 S Protein-Induced NK Cell Responses

Check if the same lab product or an alternative is used in the 5 most similar protocols
For analysis of NK-cell related responses, an ELISA-based assay was used. Therefore, 96-well ELISA plates (Thermo Fisher) were coated with SARS-CoV-2 S at 37°C for 2h. Plates were then washed and blocked with 5% BSA in PBS overnight at 4°C. NK cells were isolated from buffy coats from healthy donors (MGH blood donor center) using the RosetteSep isolation kit (Stem Cell Technologies) and NK cells were rested overnight supplemented with IL-15 (Stemcell). Serum samples were diluted 1:50 and incubated at 37°C for 2h on the ELISA plates. A staining cocktail of anti-CD107a-PE-Cy5 stain (BD), brefeldin A (Sigma), and GolgiStop (BD) was added to the NK cells and 5×104 NK cells per well were added and incubated for 5h at 37°C. NK cells were fixed and permeabilized using Perm A and B (Thermo Fisher) and surface markers were stained for with anti-CD16 APC-Cy7 (BD), anti-CD56 PE-Cy7 (BD) and anti-CD3 AlexaFluor 700 antibodies (BD). Intracellular staining included anti-IFNγ APC (BD) and anti-MIP-1β PE (BD). Acquisition occurred by flow cytometry iQue (Intellicyt), equipped with a robot arm (PAA). NK cells were defined as CD3-, CD16+ and CD56+. The ADNKA assay was performed in duplicate across two blood donors.
+ Open protocol
+ Expand
7

Human NK Cell Culture and Isolation

Check if the same lab product or an alternative is used in the 5 most similar protocols
The human NK92 cell line was obtained from the American Type Culture Collection (ATCC, Rockville, MD) and cultured in α-minimal essential medium (Welgene) supplemented with 12.5% fetal bovine serum (FBS), 12.5% horse serum, 0.2 mM myo inositol, 0.1 mM 2-mercaptoethanol, 0.02 mM folic acid, 1% antibiotics, and 20 ng/ml IL-2 in a humidified atmosphere with 5% CO2 at 37 °C. The human lung cancer lines (H358, H460, and H3122) were obtained from ATCC and cultured in RPMI medium supplemented with 10% FBS and 1% antibiotics. Primary NK cells were obtained from human cord blood provided by a local hospital (IRB approval number P01-201610-31-002), as described previously [29] (link). Briefly, CD3 cells and red blood cells were depleted from mononuclear cells with a Rosettesep cocktail (STEMCELL technologies) and CD3-depleted cells were cultured in α-minimal essential medium (Welgene) supplemented with human IL-15 (10 ng/mL), IL-21 (10 ng/mL), and 10−6 M hydrocortisone (StemCell Technologies).
+ Open protocol
+ Expand
8

Isolation and Activation of NK Cells for Coculture with MM

Check if the same lab product or an alternative is used in the 5 most similar protocols
NK cells were isolated from PB samples obtained from healthy volunteers. Undiluted PB was overlaid on a Ficoll density gradient and centrifuged at 200× g for 20 min without break. The platelet-enriched fraction was collected and stored at RT. The mononuclear cells were collected, and NK cells were isolated by negative depletion using the EasySep human NK cell isolation kit and EasySep magnet (Stemcell Technologies, Vancouver, BC, Canada), according to the manufacturer’s instructions. Isolated NK cells were cultured for 7 days in NK MACS medium (Miltenyi Biotech GmbH; Bergisch Gladbach, Germany) supplemented with human serum, IL-2 (500 U/mL,) and IL-15 (140 U/mL), both from Stemcell Technologies. Media was replenished every 3 days. MM cells were incubated with/without platelets and after incubation, cells were cocultured with/without platelet-autologous NK cells at different ratios for 5 h. Cell death was measured by flow cytometry using the Annexin V/7AAD assay (BD Biosciences).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!